organization · Reporting owner
APHC Holdings, LLC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Amneal Pharmaceuticals, Inc.
Report date July 05, 2018 · Filed July 09, 2018
Section 16 reporting ended · disclosed 2018-07-09. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-07-05 transaction · row 1
1 source rowRow 1 · 2018-07-05 · Other · Disposed 6,886,140 · Balance 0 F1: Reflects a pro rata in-kind distribution of Class A Common Stock by the Reporting Person to its members who are holders of profit participation units for no consideration. |
| Class B Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-07-05 transaction · row 2
1 source rowRow 2 · 2018-07-05 · Other · Disposed 171,260,707 · Balance 0 F2: Reflects a pro rata in-kind distribution of Class B Common Stock and Common Units by the Reporting Person to its members for no consideration. |
| Common UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-07-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-07-05 · Other · Disposed 171,260,707 · Balance 0 F3: The Common Units may be redeemed at any time for shares of the Issuer's Class A Common Stock on a 1-to-1 basis. F2: Reflects a pro rata in-kind distribution of Class B Common Stock and Common Units by the Reporting Person to its members for no consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects a pro rata in-kind distribution of Class A Common Stock by the Reporting Person to its members who are holders of profit participation units for no consideration.
F2: Reflects a pro rata in-kind distribution of Class B Common Stock and Common Units by the Reporting Person to its members for no consideration.
F3: The Common Units may be redeemed at any time for shares of the Issuer's Class A Common Stock on a 1-to-1 basis.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 05, 2018 Filed Jul 9, 2018 17:11 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | OtherCommon Units · Derivative | 171,260,707 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-019659 · doc4.xml · derivative · entry 3 APHC Holdings, LLC · CIK 0001739290 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Units · 171,260,707 shares Expires not disclosed F3 · derivative.exercise_price: The Common Units may be redeemed at any time for shares of the Issuer's Class A Common Stock on a 1-to-1 basis. F2 · kind: Reflects a pro rata in-kind distribution of Class B Common Stock and Common Units by the Reporting Person to its members for no consideration. F3 · derivative.exercise_date: The Common Units may be redeemed at any time for shares of the Issuer's Class A Common Stock on a 1-to-1 basis. F3 · derivative.expiration_date: The Common Units may be redeemed at any time for shares of the Issuer's Class A Common Stock on a 1-to-1 basis. Read SEC document |
| July 05, 2018 Filed Jul 9, 2018 17:11 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | OtherClass B Common Stock | 171,260,707 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-019659 · doc4.xml · nonDerivative · entry 2 APHC Holdings, LLC · CIK 0001739290 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: Reflects a pro rata in-kind distribution of Class B Common Stock and Common Units by the Reporting Person to its members for no consideration. Read SEC document |
| July 05, 2018 Filed Jul 9, 2018 17:11 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | OtherClass A Common Stock | 6,886,140 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-019659 · doc4.xml · nonDerivative · entry 1 APHC Holdings, LLC · CIK 0001739290 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Reflects a pro rata in-kind distribution of Class A Common Stock by the Reporting Person to its members who are holders of profit participation units for no consideration. Read SEC document |
| May 04, 2018 Filed May 8, 2018 19:28 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | ConversionCommon Units · Derivative | 12,328,767 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-011952 · doc4.xml · derivative · entry 7 APHC Holdings, LLC · CIK 0001739290 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,260,707 Underlying: Class B-1 Common Stock · 12,328,767 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Common Units may be redeemed by the Reporting Person at any time for shares of the Issuer's Class A Common Stock or Class B-1 Common Stock on a 1-to-1 basis. F2 · derivative.exercise_date: The Common Units may be redeemed by the Reporting Person at any time for shares of the Issuer's Class A Common Stock or Class B-1 Common Stock on a 1-to-1 basis. F2 · derivative.expiration_date: The Common Units may be redeemed by the Reporting Person at any time for shares of the Issuer's Class A Common Stock or Class B-1 Common Stock on a 1-to-1 basis. Read SEC document |
| May 04, 2018 Filed May 8, 2018 19:28 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | ConversionCommon Units · Derivative | 41,406,689 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-011952 · doc4.xml · derivative · entry 6 APHC Holdings, LLC · CIK 0001739290 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,589,474 Underlying: Class A Common Stock · 41,406,689 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Common Units may be redeemed by the Reporting Person at any time for shares of the Issuer's Class A Common Stock or Class B-1 Common Stock on a 1-to-1 basis. F2 · derivative.exercise_date: The Common Units may be redeemed by the Reporting Person at any time for shares of the Issuer's Class A Common Stock or Class B-1 Common Stock on a 1-to-1 basis. F2 · derivative.expiration_date: The Common Units may be redeemed by the Reporting Person at any time for shares of the Issuer's Class A Common Stock or Class B-1 Common Stock on a 1-to-1 basis. Read SEC document |
| May 04, 2018 Filed May 8, 2018 19:28 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | OtherClass B Common Stock | 53,735,465 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-011952 · doc4.xml · nonDerivative · entry 5 APHC Holdings, LLC · CIK 0001739290 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,260,707 F1 · kind: Reflects the cancellation for no consideration of Class B Common Stock in connection with the redemption of the Common Units. Read SEC document |
| May 04, 2018 Filed May 8, 2018 19:28 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | SaleClass B-1 Common Stock | 12,328,767 | $18.25 | $224,999,997.75 |
DisclosureSEC source: 0000899243-18-011952 · doc4.xml · nonDerivative · entry 4 APHC Holdings, LLC · CIK 0001739290 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| May 04, 2018 Filed May 8, 2018 19:28 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | SaleClass A Common Stock | 34,520,549 | $18.25 | $630,000,019.25 |
DisclosureSEC source: 0000899243-18-011952 · doc4.xml · nonDerivative · entry 3 APHC Holdings, LLC · CIK 0001739290 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,886,140 Read SEC document |
| May 04, 2018 Filed May 8, 2018 19:28 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | ConversionClass B-1 Common Stock | 12,328,767 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-011952 · doc4.xml · nonDerivative · entry 2 APHC Holdings, LLC · CIK 0001739290 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,328,767 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2018 Filed May 8, 2018 19:28 UTC | Amneal Pharmaceuticals, Inc. AMRX · Entity 820 | ConversionClass A Common Stock | 41,406,689 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-011952 · doc4.xml · nonDerivative · entry 1 APHC Holdings, LLC · CIK 0001739290 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,406,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.